VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ATEC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ATECAlphatec Holdings, Inc.
$9.38$1.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

ATEC logoAlphatec Holdings, Inc.(ATEC)Earnings, Financials & Key Ratios

ATEC•NASDAQ
$9.38
Price updated Jul 7, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryOrthopedics, spine, and sports medicine
AboutAlphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.Show more
  • Revenue$764M+25.0%
  • EBITDA$435K+100.8%
  • Net Income-$143M+11.6%
  • EPS (Diluted)-0.96+15.0%
  • Gross Margin69.6%+0.3%
  • EBITDA Margin0.06%+100.7%
  • Operating Margin-10.75%+51.7%
  • Net Margin-18.76%+29.2%
  • ROE-630.66%-116.2%

ATEC Price & Volume

Alphatec Holdings, Inc. (ATEC) stock price & volume — 10-year historical chart

Loading chart...

Aggressive Revenue Growth Faces Structural Leverage Constraints

Investment Thesis • Updated 2026Q1

VerdictNeutral
Growth:Expanding
Profitability:Negative
Financial:Strained
Cash Flow:Improving
Primary Risk:High leverage and insolvency

Key Thesis Takeaways

  • Alphatec Holdings demonstrates robust top-line momentum with year-over-year revenue growth consistently exceeding 20%, driven by its proceduralization strategy in the competitive spine market.
  • However, the company faces significant fundamental headwinds, including persistent operating losses and a debt-to-equity ratio that has surged to 33.03 as of 2026Q1.
  • Investors should monitor whether the recent shift toward positive free cash flow, reaching $9.6 million in 2025Q4, can be sustained to offset the ongoing reliance on stock-based compensation and high leverage.

Verdict Logic

while revenue growth is compelling, the company's precarious balance sheet and reliance on $19.4 million in quarterly stock-based compensation to mask net losses of $21.7 million in 2025Q4 warrant a cautious approach.

ATEC Growth Metrics

Alphatec Holdings, Inc. (ATEC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years15.22%
5 Years39.46%
3 Years29.62%
TTM-7.36%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM24.27%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM27.83%

Return on Capital

10 Years-30.18%
5 Years-28.22%
3 Years-22.95%
Last Year-13.75%

ATEC Recent Earnings

Alphatec Holdings, Inc. (ATEC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$0.22-2100.0%
$0.01
Rev
$192M-2.7%
$198M
Q1 2026
Feb 24, 2026
Metric
Actual
Est
EPS
$0.06+50.0%
$0.04
Rev
$213M+0.7%
$212M
Q4 2025
Oct 30, 2025
Metric
Actual
Est
EPS
$0.03+200.0%
$0.03
Rev
$197M-6.1%
$209M
Q3 2025
Jul 31, 2025
Metric
Actual
Est
EPS
$0.02+133.3%
$0.06
Rev
$186M+1.6%
$183M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.22vs $0.01-2100.0%
$192Mvs $198M-2.7%
Q1 2026Feb 24, 2026
$0.06vs $0.04+50.0%
$213Mvs $212M+0.7%
Q4 2025Oct 30, 2025
$0.03vs $0.03+200.0%
$197Mvs $209M-6.1%
Q3 2025Jul 31, 2025
$0.02vs $0.06+133.3%
$186Mvs $183M+1.6%
Based on last 12 quarters of dataView full earnings history →

Peers Comparison

Key metrics vs top competitors for Alphatec Holdings, Inc. (ATEC)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
ATEC logoATECAlphatec Holdings, Inc.Current
$9.38$1.42B-9.7724.95%-18.76%-630.66%—
NUVL logoNUVLNuvalent, Inc.
$123.77$9.1B-21.16——-42.78%—
XTNT logoXTNTXtant Medical Holdings, Inc.
$0.42$58.84M13.9814.21%1.5%3.68%—
GMED logoGMEDGlobus Medical, Inc.
$78.83$10.63B20.1116.65%18.92%13.04%—
SYK logoSYKStryker Corporation
$313.38$120.14B37.3111.16%13.21%15.1%—
ZBH logoZBHZimmer Biomet Holdings, Inc.
$89.41$17.51B25.197.2%9.05%5.77%—

Compare ATEC vs Peers

Alphatec Holdings, Inc. (ATEC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NUVL

Most directly comparable listed peer for ATEC.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare ATEC against a more recognizable public peer.

Peer Set

Compare Top 5

vs NUVL, XTNT, GMED, SYK

ATEC SEC Filings & Documents

Alphatec Holdings, Inc. (ATEC) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Mar 3, 2026·SEC

Material company update

Feb 24, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 24, 2026·SEC

FY 2025

Feb 26, 2025·SEC

FY 2024

Feb 27, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 5, 2026·SEC

FY 2025

Oct 30, 2025·SEC

FY 2025

Jul 31, 2025·SEC

Get notified when ATEC posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

ATEC Frequently Asked Questions

Alphatec Holdings, Inc. (ATEC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Alphatec Holdings, Inc.'s revenue?

Alphatec Holdings, Inc. (ATEC) reported $595.0M in revenue for fiscal year 2025. This represents a 3239% increase from $17.8M in 2004.

How fast is Alphatec Holdings, Inc. growing?

Alphatec Holdings, Inc. (ATEC) grew revenue by 25.0% over the past year. This is strong growth.

Is ATEC profitable?

Alphatec Holdings, Inc. (ATEC) reported a net loss of $125.4M for fiscal year 2025.

Dividend & Returns
What is ATEC's return on equity?

Alphatec Holdings, Inc. (ATEC) has a return on equity (ROE) of -630.7%. Negative ROE indicates the company is unprofitable.

What is Alphatec Holdings, Inc.'s free cash flow?

Alphatec Holdings, Inc. (ATEC) generated $6.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in ATEC back in 2004?

Total return calculator · dividends reinvested · 22+ years of data

See returns →